Last 48 quarters of trend data · Real Estate · Healthcare REITs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 76.38 | 44.82 | — | 30.05 | 43.05 | 50.43 | 17.07 | 25.69 | 22.79 | 35.79 | 38.50 | 33.57 | 48.47 | — | 32.26 | — | — | — | 48.17 | 20.68 | — |
| — | -11.1% | — | +17.0% | +88.9% | +40.9% | -55.7% | -23.5% | -53.0% | — | +19.3% | — | — | — | -33.0% | — | — | — | — | -23.8% | — | |
| P/S Ratio | 5.77 | 5.13 | 5.22 | 5.55 | 5.65 | 5.97 | 5.87 | 5.72 | 5.69 | 6.20 | 5.11 | 5.17 | 5.09 | 5.01 | 4.26 | 4.14 | 8.53 | 5.56 | 5.27 | 5.46 | — |
| — | -14.1% | -11.2% | -3.0% | -0.7% | -3.6% | +14.9% | +10.6% | +11.8% | +23.8% | +20.0% | +24.8% | -40.3% | -9.9% | -19.3% | -24.1% | — | +96.2% | — | -12.9% | — | |
| P/B Ratio | 1.82 | 1.80 | 1.79 | 1.77 | 1.70 | 1.61 | 1.64 | 1.55 | 1.51 | 1.61 | 1.30 | 1.25 | 1.19 | 1.12 | 0.93 | 0.89 | 0.94 | 0.94 | 0.98 | 1.03 | 0.91 |
| — | +12.3% | +9.1% | +13.6% | +12.0% | -0.1% | +25.7% | +24.7% | +27.5% | +43.0% | +40.4% | +39.5% | +26.4% | +19.0% | -4.8% | -12.9% | +3.1% | -3.8% | -16.2% | -2.6% | -14.5% | |
| P/FCF | 14.74 | 11.33 | 20.28 | 12.51 | 13.69 | 11.35 | 13.72 | 13.08 | 12.98 | 11.29 | 11.23 | 16.32 | 10.57 | 311.37 | 9.72 | 9.73 | 10.62 | 6.99 | 10.57 | 13.66 | 7.86 |
| — | -0.2% | +47.9% | -4.3% | +5.5% | +0.5% | +22.2% | -19.9% | +22.8% | -96.4% | +15.6% | +67.7% | -0.5% | +4357.6% | -8.0% | -28.7% | +35.0% | -9.2% | -10.1% | +1.4% | -43.1% | |
| EV / EBITDA | 21.52 | 14.62 | 75.37 | 20.22 | 15.66 | 16.09 | 14.84 | 14.87 | 14.91 | 15.94 | 13.90 | 14.58 | 14.75 | 9.65 | 8.84 | 8.14 | 18.48 | 10.36 | 9.40 | 9.44 | — |
| — | -9.1% | +407.8% | +36.0% | +5.1% | +0.9% | +6.8% | +2.0% | +1.1% | +65.2% | +57.2% | +79.0% | -20.2% | -6.9% | -6.0% | -13.7% | — | +120.5% | — | -7.7% | — | |
| EV / EBIT | 29.48 | 32.55 | 352.05 | 27.61 | 32.11 | 33.52 | 18.32 | 24.31 | 19.71 | 28.93 | 28.10 | 26.68 | 31.44 | 24.07 | 22.37 | 25.51 | — | 36.44 | 23.32 | 22.83 | — |
| — | -2.9% | +1821.2% | +13.5% | +62.9% | +15.9% | -34.8% | -8.9% | -37.3% | +20.2% | +25.7% | +4.6% | — | -33.9% | -4.1% | +11.7% | — | +434.1% | — | -11.8% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.0% | 58.7% | 60.9% | 61.4% | 62.0% | 63.3% | 67.7% | 67.3% | 67.2% | 67.1% | 68.9% | 67.6% | 69.5% | 69.5% | 69.4% | 70.3% | 47.8% | 69.5% | 74.8% | 75.6% | 216.1% |
| — | -7.3% | -10.1% | -8.9% | -7.6% | -5.6% | -1.8% | -0.4% | -3.3% | -3.4% | -0.7% | -3.9% | +45.4% | -0.0% | -7.3% | -6.9% | -77.9% | -20.7% | -75.1% | +0.1% | +169.5% | |
| Operating Margin | 34.1% | 25.6% | -13.6% | 17.8% | 30.5% | 31.3% | 38.0% | 36.7% | 36.9% | 36.2% | 38.0% | 34.8% | 33.2% | 62.8% | 63.4% | 63.8% | 34.9% | 62.4% | 69.2% | 69.0% | 242.8% |
| — | -18.3% | -135.7% | -51.5% | -17.4% | -13.3% | +0.1% | +5.6% | +11.0% | -42.4% | -40.1% | -45.5% | -4.7% | +0.6% | -8.3% | -7.5% | -85.6% | -26.2% | -80.4% | -0.6% | +222.2% | |
| Net Margin | 20.1% | 11.5% | -10.7% | 18.4% | 12.8% | 11.9% | 34.7% | 22.0% | 25.6% | 16.7% | 13.6% | 15.7% | 10.5% | -9.4% | 13.2% | -5.9% | -101.0% | -36.7% | 11.0% | 25.7% | 78.7% |
| — | -3.3% | -130.8% | -16.0% | -49.8% | -29.1% | +154.6% | +39.5% | +143.9% | +278.4% | +3.1% | +366.3% | +110.4% | +74.4% | +20.5% | -123.0% | -228.2% | -1136.6% | -98.6% | +13.2% | +254.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.6% | 1.0% | -0.9% | 1.5% | 1.0% | 0.8% | 2.4% | 1.5% | 1.7% | 1.1% | 0.9% | 0.9% | 0.6% | -0.5% | 0.7% | -0.3% | -2.7% | -1.5% | 0.5% | 1.2% | -0.7% |
| — | +25.7% | -137.6% | -1.6% | -43.4% | -24.8% | +179.2% | +57.1% | +181.4% | +308.2% | +21.2% | +399.7% | +122.3% | +66.1% | +42.2% | -126.1% | -273.5% | -603.7% | +113.1% | +24.5% | -166.2% | |
| ROA | 2.9% | 0.5% | -0.5% | 0.7% | 0.5% | 0.4% | 1.2% | 0.8% | 0.9% | 0.6% | 0.4% | 0.5% | 0.3% | -0.3% | 0.4% | -0.2% | -1.5% | -0.8% | 0.3% | 0.7% | -0.4% |
| — | +26.4% | -136.6% | -3.6% | -43.7% | -25.6% | +177.6% | +56.8% | +174.6% | +300.7% | +16.9% | +390.6% | +121.7% | +67.3% | +34.8% | -124.5% | -266.4% | -599.2% | +112.6% | +22.4% | -164.5% | |
| ROIC | 3.8% | 0.9% | -0.5% | 0.6% | 0.9% | 0.9% | 1.1% | 1.0% | 1.0% | 0.9% | 1.0% | 0.8% | 0.8% | 1.4% | 1.4% | 1.4% | 0.4% | 1.1% | 1.4% | 1.4% | -1.0% |
| — | +6.9% | -143.3% | -43.8% | -6.4% | -7.5% | +9.3% | +18.4% | +25.6% | -34.9% | -32.0% | -40.5% | +99.4% | +28.4% | +2.7% | -1.6% | +139.0% | -66.1% | +277.5% | +8.0% | -161.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.90 | 0.86 | 0.96 | 0.97 | 0.90 | 0.92 | 0.93 | 0.90 | 0.89 | 0.90 | 0.90 | 0.90 | 0.87 | 0.83 | 0.84 | 0.82 | 0.83 | 0.78 | 0.76 | 0.72 | 0.72 |
| — | -7.3% | +3.7% | +7.8% | +1.3% | +2.4% | +3.3% | -0.6% | +2.1% | +8.7% | +7.3% | +10.1% | +4.7% | +7.0% | +9.7% | +14.4% | +15.3% | -4.7% | +11.0% | +7.3% | +1.0% | |
| Debt / EBITDA | 5.66 | 18.93 | 108.72 | 29.07 | 21.99 | 24.19 | 21.75 | 21.83 | 22.30 | 23.15 | 22.79 | 24.73 | 25.17 | 16.52 | 16.85 | 15.70 | 35.09 | 18.80 | 16.69 | 15.59 | — |
| — | -21.7% | +400.0% | +33.2% | -1.4% | +4.5% | -4.6% | -11.7% | -11.4% | +40.1% | +35.3% | +57.5% | -28.3% | -12.1% | +0.9% | +0.7% | — | +100.5% | — | -2.1% | — | |
| Current Ratio | 0.56 | 0.32 | 43.68 | 13.85 | 0.56 | 2.59 | 2.11 | 1.37 | 0.88 | 1.01 | 1.67 | 0.83 | 2.35 | 4.30 | 4.40 | 3.65 | 1.66 | 3.58 | 4.96 | 4.39 | 4.17 |
| — | -87.7% | +1974.4% | +913.3% | -36.3% | +156.9% | +26.1% | +65.1% | -62.4% | -76.6% | -62.0% | -77.3% | +41.7% | +20.0% | -11.3% | -16.8% | -60.2% | -43.4% | +119.1% | +126.4% | +140.8% | |
| Quick Ratio | 0.56 | 0.32 | 43.68 | 13.85 | 0.56 | 2.59 | 2.11 | 1.37 | 0.88 | 1.01 | 1.67 | 0.83 | 2.35 | 4.30 | 4.40 | 3.65 | 1.66 | 3.58 | 4.96 | 4.39 | 4.17 |
| — | -87.7% | +1974.4% | +913.3% | -36.3% | +156.9% | +26.1% | +65.1% | -62.4% | -76.6% | -62.0% | -77.3% | +41.7% | +20.0% | -11.3% | -16.8% | -60.2% | -43.4% | +119.1% | +126.4% | +140.8% | |
| Interest Coverage | 2.40 | 1.98 | 0.17 | 2.39 | 1.96 | 1.67 | 3.40 | 2.50 | 2.95 | 2.00 | 1.83 | 1.94 | 1.05 | 2.05 | 2.04 | 1.74 | -0.74 | 1.39 | 2.39 | 2.55 | -4.68 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SBRA stock.
Sabra Health Care REIT, Inc.'s current P/E is 76.4x. The average P/E over the last 3 quarters is 39.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Sabra Health Care REIT, Inc.'s current operating margin is 34.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Sabra Health Care REIT, Inc.'s business trajectory between earnings reports.